A patient specific quality assurance (QA) should detect errors that originate anywhere in the treatment planning process. However, the increasing complexity of treatment plans has increased the need for improvements in the accuracy of the patient specific pretreatment verification process. This has led to the utilization of higher resolution QA methods such as the electronic portal imaging device (EPID) as well as MLC log files and it is important to know the types of errors that can be detected with these methods. In this study, we will compare the ability of three QA methods (Delta4®, MU‐EPID, Dynalog QA) to detect specific errors. Multileaf collimator (MLC) errors, gantry angle, and dose errors were introduced into five volumetric modulated arc therapy (VMAT) plans for a total of 30 plans containing errors. The original plans (without errors) were measured five times with each method to set a threshold for detectability using two standard deviations from the mean and receiver operating characteristic (ROC) derived limits. Gamma passing percentages as well as percentage error of planning target volume (PTV) were used for passing determination. When applying the standard 95% pass rate at 3%/3 mm gamma analysis errors were detected at a rate of 47, 70, and 27% for the Delta4, MU‐EPID and Dynalog QA respectively. When using thresholds set at 2 standard deviations from our base line measurements errors were detected at a rate of 60, 30, and 47% for the Delta4, MU‐EPID and Dynalog QA respectively. When using ROC derived thresholds errors were detected at a rate of 60, 27, and 47% for the Delta4, MU‐EPID and Dynalog QA respectively. When using dose to the PTV and the Dynalog method 11 of the 15 small MLC errors were detected while none were caught using gamma analysis. A combination of the EPID and Dynalog QA methods (scaling Dynalog doses using EPID images) matches the detection capabilities of the Delta4 by adding additional comparison metrics. These additional metrics are vital in relating the QA measurement to the dose received by the patient which is ultimately what is being confirmed.
Purpose: Water scanning systems are commonly used for data collection to characterize dosimetric properties of photon and electron beams, and the commissioning of such systems has been previously described. The aim in this study, however, was to investigate tank-specific dependencies as well as conduct a dosimetric comparison between four distinct water scanning systems. Methods: Four water scanning systems were studied including the PTW MP3-M Phantom Tank, the Standard Imaging DoseView 3D, the IBA Blue Phantom, and the Sun Nuclear 3D Scanner. Mechanical accuracy and reproducibility was investigated by driving the chamber holder to nominal positions relative to a zero point and using a leveled caliper with 30 cm range to measure the actual position. Dosimetric measurements were also performed not only to compare percent-depth-dose (PDD) curves and profiles between tanks but also to assess dependencies such as directionality, scanning speed, and reproducibility for each tank individually. A PTW Semiflex 31010 ionization chamber with a sensitive volume of 0.125 cc was used at a Varian Clinac 2300 linear accelerator. Results: Mechanical precision was ensured to within 0.1 mm with the standard deviation (SD) of reproducibility <0.1 mm for measurements made with calipers. Dependencies on scanning direction and speed are presented. 6 MV PDDs between tanks agreed to within 0.6% relative to an averaged PDD beyond dmax and within 2.5% in the build-up region. Specifically, the maximum difference was 1.0% between MP3-M and Blue Phantom at 6.1 cm depth. Lateral profiles agreed between tanks within 0.5% in the central 80% of the field. 6 MeV PDD maximum difference was 1.3% occurring at the steepest portion, where the R50 was nevertheless within 0.6 mm across tanks. Setup uncertainties estimated at ≤1 mm are presumed to have contributed some of the difference between water tank data. Conclusion: Modern water scanning systems have achieved high accuracy across vendors, but commissioning tests nevertheless reveal tank-specific dependencies. This study not only ensures confidence in the individual systems but also provides the medical physicist with an understanding of variation in water tank properties between vendors.
Two parameters in high-frequency ultrasound (20-80 MHz) have been found to be sensitive to a range of pathologies in resected margins from breast conservation surgery: The number of peaks (the peak density) in the waveform spectrum and the slope of the Fourier transform of the waveform spectrum. Previous studies have indicated that peak density and slope may correlate to microscopic heterogeneity in tissue structure, which is modified by atypical and malignant processes. To test this hypothesis, through-transmission and pulse-echo measurements were acquired from gelatin-based phantoms containing polyethylene microspheres and nylon fibers (2.5-10% volume concentration). Multipole methods were also used to model through-transmission measurements of tumor progression in lobular carcinoma in situ. The simulated breast tissue contained 1000-2000 nucleated cells with random lobular cavities. The peak densities of the heterogeneous phantoms were significantly greater than those of the homogeneous control samples, whereas the slopes were less. Similarly, the models produced spectra with peak densities that increased with malignant cell proliferation. The results are consistent with breast tissue data, and provide a physical mechanism for the use of peak density and slope in the imaging of breast tissues with atypical and malignant pathologies. This work was supported by Utah Valley University.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.